Vol 9, No 3 (2018)

Date published: 2018-10-17

Table of Contents

open access

EDITORIAL

Od Redakcji

Krzysztof Warzocha

Editorial

Hematologia 2018;9(3):165-166.
REVIEW ARTICLES

Principles of amyloidosis classification and nomenclature

Bartosz Puła, Sonia Dębek, Krzysztof Jamroziak

Review paper

DOI: 10.5603/Hem.2018.0022
Hematologia 2018;9(3):167-172.

AA amyloidosis - causes, diagnostics, therapeutic options

Ewa Więsik-Szewczyk

Review paper

DOI: 10.5603/Hem.2018.0023
Hematologia 2018;9(3):173-180.

Diagnostics and treatment of AL amyloidosis

Krzysztof Jamroziak, Paolo Milani, Bartosz Puła, Sonia Dębek, Giovanni Palladini

Review paper

DOI: 10.5603/Hem.2018.0024
Hematologia 2018;9(3):181-195.

Significance of minimal residual disease evaluation in AL amyloidosis

Agnieszka Krzywdzińska, Iwona Solarska, Bartosz Puła, Krzysztof Jamroziak

Review paper

DOI: 10.5603/Hem.2018.0025
Hematologia 2018;9(3):196-201.

Doxycycline in the treatment of systemic amyloidosis with cardiac involvement.

Justyna Łyczkowska-Piotrowska, Aleksander Salomon-Perzyński, Agnieszka Końska, Krzysztof Jamroziak

Review paper

DOI: 10.5603/Hem.2018.0027
Hematologia 2018;9(3):202-207.

Renal amyloidosis

Wojciech Wołyniec, Agnieszka Perkowska-Ptasińska, Alicja Dębska-Ślizień, Tomasz Liberek, Magdalena Durlik

Review paper

DOI: 10.5603/Hem.2018.0028
Hematologia 2018;9(3):208-221.

Light-chain cardiac amyloidosis from the cardiologists’ point of view

Jacek Grzybowski, Justyna Anna Szczygieł, Monika Gawor, Piotr Michałek, Agnieszka Sioma, Natalia Ojrzyńska, Łukasz Mazurkiewicz, Marta Legatowicz-Koprowska, Ewa Walczak, Maria Franaszczyk, Magdalena Marczak

Review paper

DOI: 10.5603/Hem.2018.0029
Hematologia 2018;9(3):222-238.
CASE REPORTS

Fluctuating Guillain-Barré syndrome in AL systemic amyloidosis as a progression indicator?

Anna Suska, Jacek Matyszkiewicz, Artur Jurczyszyn

Case report

DOI: 10.5603/Hem.2018.0030
Hematologia 2018;9(3):239-244.

How we treat a patient with intermediate-risk light chain amyloidosis? The role of doxycycline in cardiac amyloidosis.

Aleksander Salomon-Perzyński, Agnieszka Końska, Bartosz Puła, Justyna Łyczkowska-Piotrowska, Krzysztof Jamroziak

Case report

DOI: 10.5603/Hem.2018.0031
Hematologia 2018;9(3):245-253.

Novel diagnostic pathways in cardiac amyloidosis. Case-series study on transthyretin amyloidosis.

Paweł Rubiś, Ewa Dziewięcka, Katarzyna Holcman, Wojciech Szot, Sylwia Wiśniowska-Śmiałek, Agata Leśniak-Sobelga, Marta Hlawaty, Piotr Podolec, Magdalena Kostkiewicz

Case report

DOI: 10.5603/Hem.2018.0032
Hematologia 2018;9(3):254-264.
IN THE OPINION OF THE (FORMER) CONSULTANT

Zdaniem (byłego) konsultanta

Wiesław Wiktor Jędrzejczak

Other materials agreed with the Editors

DOI: 10.5603/Hem.2018.0033
Hematologia 2018;9(3):265.
TEST QUESTIONS

Pytania testowe

Other materials agreed with the Editors

DOI: 10.5603/Hem.2018.0034
Hematologia 2018;9(3):266-268.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.